Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam hydrochloride in idiopathic bile acid diarrhoea
ISRCTN68585853Phase 2Completed
- Sponsor
- Cosmo Pharmaceuticals
- Start
- Dec 2024
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01
Overview
Phase 2, randomised, double-blind trial of colesevelam in idiopathic bile acid diarrhea (IBAD) (3 arms), sponsored by Cosmo Pharmaceuticals. Started Dec 2024; status: completed.
02
Drugs
colesevelam
03
Conditions
idiopathic bile acid diarrhea (IBAD)
Beyond the preview
Go deeper on ISRCTN68585853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN68585853.